News Search Results
Oct 20, 2025, 06:30 ET IDEAYA Biosciences Announces Positive Phase 2 Data for Darovasertib in the Neoadjuvant Setting of Primary Uveal Melanoma in a Proffered Paper Oral Presentation at ESMO 2025
primary uveal melanoma for EN eligible patients SOUTH SAN FRANCISCO, Calif., Oct. 20, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision
More news about: IDEAYA Biosciences, Inc.
Oct 20, 2025, 06:00 ET IDEAYA Biosciences Reports Positive Median Overall Survival Data from Phase 2 Trial of the Darovasertib and Crizotinib Combination in First-line Metastatic Uveal Melanoma at the 2025 Society for Melanoma Research Congress
months and disease control rate (DCR) of 90% SOUTH SAN FRANCISCO, Calif., Oct. 20, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision
More news about: IDEAYA Biosciences, Inc.
Oct 19, 2025, 10:30 ET VT3989, Vivace Therapeutics' Best-in-Class, Hippo Pathway-Targeting Therapy, Demonstrates Promising Antitumor Activity in Refractory Mesothelioma
targeting the Hippo pathway. The company is pursuing a first-in-class approach to treat human carcinomas of high unmet medical needs. Based in San Francisco Bay Area, the company has raised $105 million to date. For more information, please visit
More news about: Vivace Therapeutics, Inc.
Oct 17, 2025, 23:48 ET PRIVACY ALERT: PeopleGuru, Inc. Under Investigation for Data Breach of Records
SAN FRANCISCO, Oct. 17, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating a data breach that led to unauthorized access to the sensitive information of individuals affiliated
More news about: Schubert Jonckheer & Kolbe LLP
Oct 17, 2025, 16:33 ET Gunderson Dettmer and Alpha Edison Announce Winner of PitchLive.LA During LA Tech Week
offices in key venture markets throughout the world – Silicon Valley, Ann Arbor, Atlanta, Austin, Beijing, Boston, Los Angeles, New York, San Diego, San Francisco, São Paulo and Singapore. About Alpha Edison Alpha Edison
More news about: Gunderson Dettmer
Oct 17, 2025, 15:59 ET dQ&A Announces Beta Release of New AI Insights Platform - Instant, Reliable Insights for the Diabetes Market
delivers trustworthy, data-driven answers in seconds. SAN FRANCISCO, Oct. 17, 2025 /PRNewswire/ -- dQ&A, the leader in diabetes market research, today announced the beta
More news about: dQ&A Market Research
Oct 17, 2025, 15:36 ET At 2025 STAT Summit, Guests including Joe Kennedy III, AMA President, Former NIH Leaders, Explore CRISPR, Pharma, Public Health, and More
STAT's main newsroom is located in Boston, and it also has reporters in Washington, D.C., New York City, London, Los Angeles, San Francisco, San Diego, Chicago, and Minneapolis. About Boston Globe Media:
More news about: STAT
Oct 17, 2025, 14:02 ET The Inner Circle acknowledges Ilene Fennoy, MD, MPH, as a Pinnacle Professional Member Inner Circle of Excellence
journey began with a Bachelor of Arts in psychology from Stanford University, followed by a Doctor of Medicine from the University of California San Francisco School of Medicine. She completed her pediatric internship and residency at Montefiore Hospital and a postdoctoral fellowship at Columbia University's
More news about: The Inner Circle
Oct 17, 2025, 14:02 ET The Inner Circle acknowledges, Anna S Rickell as a Pinnacle Professional Member Inner Circle of Excellence
graduation, Anna relocated to Los Angeles, where she began working in a Mental Health Clinic with individuals and groups. She later moved to the San Francisco area and served as a Caseworker at a Family Service agency, working with both children and adults. She led two groups—one for adults and another
More news about: The Inner Circle
Oct 17, 2025, 13:00 ET Indiegogo Launches Next-Generation Crowdfunding Platform
for the next decade of crowdfunding innovation. SAN FRANCISCO, Oct. 17, 2025 /PRNewswire/ -- Indiegogo, one of the world's leading crowdfunding platforms, today unveiled
More news about: Indiegogo
Oct 17, 2025, 11:10 ET Call for Entries Issued for Startup Achievements Across All Industries and Regions
Achievement of the Year SAN FRANCISCO, Oct. 17, 2025 /PRNewswire/ -- The Globee® Awards, organizers of ten premier data-driven business
More news about: Globee Awards
Oct 17, 2025, 10:29 ET H.I.G. WhiteHorse verstrekt financiering aan Summit Group
investeringsmaatschappij met $ 70 miljard aan kapitaal onder beheer.* Gevestigd in Miami en met kantoren in Atlanta, Boston, Chicago, Los Angeles, New York, San Francisco en Stamford in de Verenigde Staten, evenals internationale filialen in Hamburg, Londen, Luxemburg, Madrid, Milaan, Parijs, Bogotá, Rio de Janeiro,
More news about: H.I.G. Capital
Oct 17, 2025, 10:22 ET H.I.G. WhiteHorse stellt Finanzierung für Summit Group bereit
verwalteten Kapital von 70 Milliarden US-Dollar.* Mit Hauptsitz in Miami und Niederlassungen in Atlanta, Boston, Chicago, Los Angeles, New York, San Francisco und Stamford in den Vereinigten Staaten sowie internationalen Tochtergesellschaften in Hamburg, London, Luxemburg, Madrid, Mailand, Paris, Bogotá,
More news about: H.I.G. Capital
Oct 17, 2025, 10:20 ET H.I.G. WhiteHorse fournit un financement à Summit Group
avec 70 milliards de dollars de capitaux sous gestion*. Basée à Miami et disposant de bureaux à Atlanta, Boston, Chicago, Los Angeles, New York, San Francisco et Stamford aux États-Unis, ainsi que de filiales internationales à Hambourg, Londres, Luxembourg, Madrid, Milan, Paris, Bogota, Rio de Janeiro,
More news about: H.I.G. Capital
Oct 17, 2025, 09:50 ET Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation
chemotherapy. GT Biopharma, Inc. (NASDAQ: GTBP) is a clinical-stage biotechnology company headquartered in San Francisco that's focused on harnessing the power of the immune system to fight cancer. The firm is currently advancing innovative immunotherapy treatments
More news about: Equity Insider
Oct 17, 2025, 09:27 ET aTyr Pharma, Inc.'s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman
SAN FRANCISCO, Oct. 17, 2025 /PRNewswire/ -- A federal class-action lawsuit has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) following a devastating 83% drop in the biotech company's
More news about: Hagens Berman Sobol Shapiro LLP
Oct 17, 2025, 09:25 ET KBR, Inc. (KBR) Faces Securities Class Action Amid TRANSCOM Contract Termination-Hagens Berman
KBR Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, Oct. 17, 2025 /PRNewswire/ -- A new class-action lawsuit is targeting KBR, Inc. (NYSE: KBR), alleging
More news about: Hagens Berman Sobol Shapiro LLP
Oct 17, 2025, 09:25 ET Arkestro anuncia la expansión de clientes con Chevron, para impulsar la transformación de las adquisiciones predictivas en los mercados a nivel mundial
el respaldo de Aramco Ventures y Altira Group. SAN FRANCISCO, 17 de octubre de 2025 /PRNewswire-HISPANIC PR WIRE/ --
More news about: Arkestro
Oct 17, 2025, 09:21 ET LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and Refund Woes in Key Segments, According to Hagens Berman
Losses Encouraged to Contact Hagens Berman Before Oct. 27th Deadline SAN FRANCISCO, Oct. 17, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been
More news about: Hagens Berman Sobol Shapiro LLP
Oct 17, 2025, 09:19 ET Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman
Losses Encouraged to Contact Hagens Berman Before Oct. 21st Deadline SAN FRANCISCO, Oct. 17, 2025 /PRNewswire/ -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals
More news about: Hagens Berman Sobol Shapiro LLP
Oct 17, 2025, 09:17 ET AI 4-DAY DEADLINE ALERT: Investors Allege Misleading Statements in C3.ai (AI) Class Action Lawsuit-- Hagens Berman
with Losses Encouraged to Contact the Firm Before Oct. 21st Deadline SAN FRANCISCO, Oct. 17, 2025 /PRNewswire/ -- A new class action lawsuit is targeting enterprise AI software company C3.ai
More news about: Hagens Berman Sobol Shapiro LLP
Oct 17, 2025, 09:00 ET ENCORD LAUNCHES WORLD'S LARGEST OPEN SOURCE MULTIMODAL DATASET TO ACCELERATE MULTIMODAL AI DEVELOPMENT
Training Time and Compute Requirements for Builders SAN FRANCISCO, Oct. 17, 2025 /PRNewswire/ --
More news about: Encord
Oct 17, 2025, 09:00 ET Asymmetric Capital Partners Announces $137 Million Fund II to Back Early Stage Founders
portfolio and platform Michele Spitzer, and chief operating officer Sarah Unger Biggs, actively pursues investments in New York City, Boston, and San Francisco. Media ContactKelsey Cullen, KCPR
More news about: Asymmetric Capital Partners
Oct 17, 2025, 09:00 ET Precision Oncology Approaches Drive $312B Market Transformation
platforms4. GT Biopharma, Inc. (NASDAQ: GTBP) is a clinical-stage biotechnology company headquartered in San Francisco that's focused on harnessing the power of the immune system to fight cancer. The firm is currently advancing innovative immunotherapy treatments
More news about: USA News Group
Oct 17, 2025, 08:30 ET Chain Integrates CloneOps Voice AI to Automate Track-and-Trace and Booking for Freight Brokers
SAN FRANCISCO, Oct. 17, 2025 /PRNewswire/ -- Chain, the AI-powered freight visibility software used by brokerages across the U.S., today announced an integration with CloneOps.ai to launch
More news about: Chain